Ablative radiation therapy to restrain everything safely treatable (ARREST): study protocol for a phase I trial treating polymetastatic cancer with stereotactic radiotherapy

BACKGROUND: Patients with polymetastatic cancer are most often treated with systemic therapy to improve overall survival and/or delay progression, with palliative radiotherapy reserved for sites of symptomatic disease. Stereotactic ablative radiotherapy (SABR) has shown promise in the treatment of o...

Descripción completa

Detalles Bibliográficos
Autores principales: Bauman, Glenn S., Corkum, Mark T., Fakir, Hatim, Nguyen, Timothy K., Palma, David A.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2021
Materias:
Study Protocol
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8048078/
https://www.ncbi.nlm.nih.gov/pubmed/33853550
http://dx.doi.org/10.1186/s12885-021-08020-2

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8048078/
https://www.ncbi.nlm.nih.gov/pubmed/33853550
http://dx.doi.org/10.1186/s12885-021-08020-2

Ejemplares similares